← Back to Search

CEASE + Biomarker Outreach for Helping Parents Quit Tobacco (ABC Quit Trial)

N/A

Recruiting

Led By Jonathan P Winickoff, MD, MPH

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Child 12 years old or younger presenting for a visit.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 45 months

Awards & highlights

ABC Quit Trial Summary

This trial will test if adding extra measure and outreach for tobacco exposure will improve a parental tobacco control intervention that will be integrated into pediatric practice.

Who is the study for?

This trial is for parents or legal guardians who smoke and have a child 12 years old or younger, visiting the pediatrician. The parent must be an English speaker over 18 years old, and their child should have a blood draw scheduled during the visit.Check my eligibility

What is being tested?

The study tests if adding biomarker checks to regular pediatric visits helps identify tobacco smoke exposure more effectively and improves quitting support for smoking parents. It compares standard CEASE intervention with CEASE plus biomarker feedback (CEASE + BIO).See study design

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, there are no direct side effects like those seen with drugs. However, participants may experience stress or discomfort related to discussions about smoking habits.

ABC Quit Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is 12 years old or younger.

ABC Quit Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 45 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~45 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 45 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Parental quit rate

Secondary outcome measures

Children's tobacco smoke exposure

Counseling about cessation

Smoke

+6 more

Other outcome measures

Cost per quit

ABC Quit Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CEASE + BIOExperimental Treatment2 Interventions

Those assigned to the Experimental CEASE + BIO arm will receive the CEASE intervention plus Biomarker Informed Outreach (BIO).

Group II: CEASEActive Control1 Intervention

Those assigned to the Active Comparator arm will receive the CEASE intervention.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER

1,381 Previous Clinical Trials

1,587,907 Total Patients Enrolled

1 Trials studying Tobacco Addiction

136 Patients Enrolled for Tobacco Addiction

University of RochesterOTHER

840 Previous Clinical Trials

533,382 Total Patients Enrolled

Icahn School of Medicine at Mount SinaiOTHER

861 Previous Clinical Trials

524,408 Total Patients Enrolled

Media Library

CEASE Clinical Trial Eligibility Overview. Trial Name: NCT04832659 — N/A

Tobacco Addiction Research Study Groups: CEASE, CEASE + BIO

Tobacco Addiction Clinical Trial 2023: CEASE Highlights & Side Effects. Trial Name: NCT04832659 — N/A

CEASE 2023 Treatment Timeline for Medical Study. Trial Name: NCT04832659 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for individuals to participate in this clinical research?

"The information on clinicaltrials.gov reports that this particular medical trial is not currently open for recruitment. The initial posting date was December 1st 2022, and the last modification to the page was November 8th 2022. Nonetheless, there are 111 other studies actively looking for participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Biomarkers in Children to Help Parents Quit Tobacco

Jonathan P. Winickoff, MD, MPH 2023. "Assessment of Biomarkers in Children to Help Parents Quit Tobacco". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04832659.